Trial Details

ACTIVE_NOT_RECRUITING
Basic Information
Clinical ID c1343
Identifier NCT03679546
Trial Title EFFICACI : EFFicacy of Intravenous Infliximab Versus Vedolizumab After Failure of subCutaneous Anti-TNF in Patients With UlCerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Ulcerative Colitis
Interventions DRUG: Infliximab|DRUG: Vedolizumab Injection
Participant Information
Sponsor Rennes University Hospital
City Amiens
Country/Region France
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE4
Time Information
Start Date 2019-01-04
Primary Completion Date 2024-12-31
Completion Date 2025-05-31